Silva AR, Bernardo A, Costa J, Cardoso A, Santos P, de Mesquita MF, Vaz Patto J, Moreira P, Silva ML, Padro P
Injectable GLP-1s currently have the most established weight loss evidence base, with tirzepatide showing the largest reductions in head-to-head trials, but oral options have closed much of the gap
Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review. Obesity Pillars
Since GLP-1 receptor agonists help regulate blood sugar and appetite, its important to focus on protein-rich, whole-food snacks that support stable blood sugar levels and sustained energy
Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals
Chung MK, et al